Phio Pharmaceuticals Announces Upcoming Podium Presentation at the Advanced Therapies USA 2025 Congress

About this update from Phio Pharmaceuticals Corp.

[{"type":"text","content":"Presenting INTASYL siRNA Drug Technology","length":40,"tagName":"p","attribs":{"class":"nfSubHeading"},"className":""},{"type":"text","content":"King of Prussia, Pennsylvania--(Newsfile Corp. - November 17, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that a podium presentation highlighting INTASYL® siRNA Drug Technology will be held at the Advanced Therapies USA 2025 Congress in Philadelphia, PA at the Pennsylvania Convention Center from November 18-19, 2025.","length":499,"tagName":"p"},{"type":"text","content":"Podium Presentation Details are as follows:","length":43,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"width:25%;vertical-align:top;","val":[{"type":"text","content":"Title:","length":6,"tagName":"p","attribs":{}}]},{"style":"width:75%;vertical-align:top;","val":[{"type":"text","content":"INTASYL® Synthesized siRNA Drug TechnologyDown-regulating Gene Expression","length":74,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"width:25%;vertical-align:top;","val":[{"type":"text","content":"Presenting Author:","length":18,"tagName":"p","attribs":{}}]},{"style":"width:75%;vertical-align:top;","val":[{"type":"text","content":"Melissa Maxwell, M.S.","length":21,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"width:25%;vertical-align:top;","val":[{"type":"text","content":"Date:","length":5,"tagName":"p","attribs":{}}]},{"style":"width:75%;vertical-align:top;","val":[{"type":"text","content":"November 18, 2025","length":17,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"width:25%;vertical-align:top;","val":[{"type":"text","content":"Location:","length":9,"tagName":"p","attribs":{}}]},{"style":"width:75%;vertical-align:top;","val":[{"type":"text","content":"Innovation Showcase (Track 2, Seminar Theatre)","length":46,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"width:25%;vertical-align:top;","val":[{"type":"text","content":"Time:","length":5,"tagName":"p","attribs":{}}]},{"style":"width:75%;vertical-align:top;","val":[{"type":"text","content":"1:15 PM EDT","length":11,"tagName":"p","attribs":{}}]}]}],"length":262},{"type":"text","content":" ","length":6,"tagName":"p"},{"type":"text","content":""The INTASYL ...

More updates from Phio Pharmaceuticals Corp.